Loading...

Souvik Sarkar

Title(s)Assistant Professor, Gastroenterology And Hepatology
SchoolUniversity of California, Davis
Phone916-734-3751
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, Reeve BB, Serper M, Reau N, Reddy KR, Di Bisceglie AM, Nelson DR, Golin CE, Lim JK, Fried MW. Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)". J Hepatol. 2020 Mar; 72(3):592-593. PMID: 31889556.
      View in: PubMed
    2. Piao C, Koul A, Gui D, Chen LX, Sarkar S. Noncirrhotic Portal Hypertension Secondary to Nodular Regenerative Hyperplasia Postrenal Transplant. ACG Case Rep J. 2019 Dec; 6(12):e00257. PMID: 32042840.
      View in: PubMed
    3. Serper M, Evon DM, Stewart PW, Lok AS, Amador J, Reeve BB, Golin CE, Fried MW, Reddy KR, Sterling RK, Sarkar S, Di Bisceglie AM, Lim JK, Nelson DR, Reau N. Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals. J Gen Intern Med. 2019 Oct 28. PMID: 31659661.
      View in: PubMed
    4. Zuo Y, Sarkar S, Corwin MT, Olson K, Badawi RD, Wang G. Structural and practical identifiability of dual-input kinetic modeling in dynamic PET of liver inflammation. Phys Med Biol. 2019 09 05; 64(17):175023. PMID: 31051490.
      View in: PubMed
    5. Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, Reeve BB, Serper M, Reau N, Rajender Reddy K, Di Bisceglie AM, Nelson DR, Golin CE, Lim JK, Fried MW. Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study. J Hepatol. 2019 Sep; 71(3):486-497. PMID: 31096006.
      View in: PubMed
    6. Piao C, Terrault NA, Sarkar S. Telemedicine: An Evolving Field in Hepatology. Hepatol Commun. 2019 May; 3(5):716-721. PMID: 31061958.
      View in: PubMed
    7. Mokkarala S, Johnson C, Sarkar S, Rudas RJ. Family Practitioner-Directed Hepatitis C Therapy With Direct-Acting Antivirals Achieves High-Sustained Virologic Response in Prison Population. J Correct Health Care. 2019 04; 25(2):134-142. PMID: 30866706.
      View in: PubMed
    8. Mordaunt CE, Kieffer DA, Shibata NM, Czlonkowska A, Litwin T, Weiss KH, Zhu Y, Bowlus CL, Sarkar S, Cooper S, Wan YY, Ali MR, LaSalle JM, Medici V. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. Epigenetics Chromatin. 2019 02 01; 12(1):10. PMID: 30709419.
      View in: PubMed
    9. Sarkar S, Corwin MT, Olson KA, Stewart SL, Liu CH, Badawi RD, Wang G. Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic 18F-FDG PET. AJR Am J Roentgenol. 2019 03; 212(3):529-537. PMID: 30673340.
      View in: PubMed
    10. Benjamin Spencer, Souvik Sarkar, Kristin Olson, Michael T. Corwin, Ramsey D. Badawi, Guobao Wang. Dual-Input Kinetic Modeling in Dynamic PET: Clinical Evaluation of the Impact of Time-of-Flight Imaging. 2018 IEEE Nuclear Science Symposium and Medical Imaging Conference Proceedings (NSS/MIC). 2018 Nov 1; 1-4.
      View in: Publisher Site
    11. Evon DM, Stewart PW, Amador J, Serper M, Lok AS, Sterling RK, Sarkar S, Golin CE, Reeve BB, Nelson DR, Reau N, Lim JK, Reddy KR, Di Bisceglie AM, Fried MW. A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One. 2018; 13(8):e0196908. PMID: 30067745.
      View in: PubMed
    12. Kuftinec G, Loehfelm T, Corwin M, Durbin-Johnson B, Candido M, Hluhanich R, Sarkar S. De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents. Hepat Oncol. 2018 Jan; 5(1):HEP06. PMID: 30302197.
      View in: PubMed
    13. Wang G, Corwin MT, Olson KA, Badawi RD, Sarkar S. Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function. Phys Med Biol. 2018 07 24; 63(15):155004. PMID: 29847315.
      View in: PubMed
    14. Wang T, Yang W, Karakas S, Sarkar S. NASH in Nondiabetic Endocrine Disorders. Metab Syndr Relat Disord. 2018 09; 16(7):315-320. PMID: 29873585.
      View in: PubMed
    15. Evon DM, Amador J, Stewart P, Reeve BB, Lok AS, Sterling RK, Di Bisceglie AM, Reau N, Serper M, Sarkar S, Lim JK, Golin CE, Fried MW. Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy. Aliment Pharmacol Ther. 2018 Apr; 47(7):1001-1011. PMID: 29377191.
      View in: PubMed
    16. Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Rehman RB, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y. Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms. Fatigue. 2018; 6(1):5-19. PMID: 30546968.
      View in: PubMed
    17. Corwin MT, Lee AY, Fananapazir G, Loehfelm TW, Sarkar S, Sirlin CB. Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication. AJR Am J Roentgenol. 2018 Jan; 210(1):85-90. PMID: 29023148.
      View in: PubMed
    18. Koo P, Yung V, Dutta A, Sarkar S. Choosing a Career in Advanced Endoscopy or General Gastroenterology. Dig Dis Sci. 2017 06; 62(6):1409-1411. PMID: 28405857.
      View in: PubMed
    19. Evon DM, Golin CE, Stewart P, Fried MW, Alston S, Reeve B, Lok AS, Sterling RK, Lim JK, Reau N, Sarkar S, Nelson DR, Reddy KR, Di Bisceglie AM. Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment. Contemp Clin Trials. 2017 06; 57:58-68. PMID: 28342989.
      View in: PubMed
    20. Singh S, Kuftinec GN, Sarkar S. Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature. J Clin Transl Hepatol. 2017 Mar 28; 5(1):76-81. PMID: 28507930.
      View in: PubMed
    21. Justice AC, Esserman D, Sarkar S, Levin FL, Skanderson M, Lim JK. Reply to: "Hepatitis C testing in U.S. veterans born 1945-1965: An update". J Hepatol. 2017 01; 66(1):239. PMID: 27717863.
      View in: PubMed
    22. Chak EW, Sarkar S, Bowlus C. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. Dig Dis Sci. 2016 10; 61(10):2776-2783. PMID: 27234269.
      View in: PubMed
    23. Sarkar S, Esserman DA, Skanderson M, Levin FL, Justice AC, Lim JK. Disparities in hepatitis C testing in U.S. veterans born 1945-1965. J Hepatol. 2016 08; 65(2):259-65. PMID: 27130843.
      View in: PubMed
    24. Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci. 2016 Apr; 61(4):1186-96. PMID: 26831489.
      View in: PubMed
    25. Sarkar S, Mitchell KA, Lim JK, Oikonomou I, Jakab S. Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C. ACG Case Rep J. 2015 Oct; 3(1):42-4. PMID: 26504877.
      View in: PubMed
    26. Sarkar S, Bowlus CL. Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches. Clin Liver Dis. 2016 Feb; 20(1):67-77. PMID: 26593291.
      View in: PubMed
    27. Sarkar S, Rivera EM, Engle RE, Nguyen HT, Schechterly CA, Alter HJ, Liang TJ, Purcell RH, Hoofnagle JH, Ghany MG. An Epidemiologic Investigation of a Case of Acute Hepatitis E. J Clin Microbiol. 2015 Nov; 53(11):3547-52. PMID: 26338861.
      View in: PubMed
    28. Sarkar S, Lim JK. Advances in interferon-free hepatitis C therapy: 2014 and beyond. Hepatology. 2014 Apr; 59(4):1641-4. PMID: 24590916.
      View in: PubMed
    29. Rotman Y, Noureddin M, Feld JJ, Guedj J, Witthaus M, Han H, Park YJ, Park SH, Heller T, Ghany MG, Doo E, Koh C, Abdalla A, Gara N, Sarkar S, Thomas E, Ahlenstiel G, Edlich B, Titerence R, Hogdal L, Rehermann B, Dahari H, Perelson AS, Hoofnagle JH, Liang TJ. Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. Gut. 2014 Jan; 63(1):161-9. PMID: 23396509.
      View in: PubMed
    30. Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH. Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. J Hepatol. 2012 Nov; 57(5):946-52. PMID: 22760009.
      View in: PubMed
    31. Hoofnagle JH, Sarkar S. Fatigue and serum carnitine levels in chronic liver disease. Aliment Pharmacol Ther. 2011 Jun; 33(11):1252-3. PMID: 21535052.
      View in: PubMed
    32. Murray JW, Sarkar S, Wolkoff AW. Single vesicle analysis of endocytic fission on microtubules in vitro. Traffic. 2008 May; 9(5):833-847. PMID: 18284582.
      View in: PubMed
    33. Nath S, Bananis E, Sarkar S, Stockert RJ, Sperry AO, Murray JW, Wolkoff AW. Kif5B and Kifc1 interact and are required for motility and fission of early endocytic vesicles in mouse liver. Mol Biol Cell. 2007 May; 18(5):1839-49. PMID: 17360972.
      View in: PubMed
    34. Sarkar S, Bananis E, Nath S, Anwer MS, Wolkoff AW, Murray JW. PKCzeta is required for microtubule-based motility of vesicles containing the ntcp transporter. Traffic. 2006 Aug; 7(8):1078-91. PMID: 16734659.
      View in: PubMed